| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.21 | 4e-10 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.21 | 6e-10 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-09 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.26 | 3e-09 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-09 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.17 | 8e-09 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-08 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-08 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-08 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.28 | 2e-08 |